Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix

References

• Xie J, Bi Y, Zhang H, et al. Cell-Penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front Pharmacol. 2020;11:697.
   PubMed Web of Science ®Google Scholar
• Silva S, Almeida AJ, Vale N. Combination of cell-penetrating peptides with nanoparticles for therapeutic application: a review. Biomolecules. 2019;9(1):22.
   Web of Science ®Google Scholar
• Hu H, Wang J, Wang H, et al. Cell-penetrating peptide-based nanovehicles potentiate lymph metastasis targeting and deep penetration for anti-metastasis therapy. Theranostics. 2018;8(13):3597–3610.
   PubMed Web of Science ®Google Scholar
• Shuai Q, Cai Y, Zhao G, et al. Cell-Penetrating peptide modified PEG-PLA micelles for efficient PTX delivery. Int J Mol Sci. 2020;21(5):1856.
   Web of Science ®Google Scholar
• Vives E, Brodin P, Lebleu B. A truncated HIV-1 TAT protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997;272(25):16010–16017.
   PubMed Web of Science ®Google Scholar
• Joliot A, Pernelle C, Deagostini-Bazin H, et al. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci U S A. 1991;88(5):1864–1868.
   PubMed Web of Science ®Google Scholar
• Reissmann S. Cell penetration: scope and limitations by the application of cell-penetrating peptides. J Pept Sci. 2014;20(10):760–784.
   PubMed Web of Science ®Google Scholar
• Kalafatovic D, Giralt E. Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity. Molecules. 2017;22(11):1929.
   PubMed Web of Science ®Google Scholar
• Eiriksdottir E, Konate K, Langel U, et al. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim Biophys Acta. 2010;1798(6):1119–1128.
   PubMed Web of Science ®Google Scholar
• Nygren P, Lundqvist M, Liedberg B, et al. Secondary structure in de novo designed peptides induced by electrostatic interaction with a lipid bilayer membrane. Langmuir. 2010;26(9):6437–6448.
   PubMed Web of Science ®Google Scholar
• Futaki S, Suzuki T, Ohashi W, et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 2001;276(8):5836–5840.
   PubMed Web of Science ®Google Scholar
• Xu D, Esko JD. Demystifying heparan sulfate-protein interactions. Annu Rev Biochem. 2014;83:129–157.
   PubMed Web of Science ®Google Scholar
• Prince RN, Schreiter ER, Zou P, et al. The heparin-binding domain of HB-EGF mediates localization to sites of cell–cell contact and prevents HB-EGF proteolytic release. J Cell Sci. 2010;123(Pt 13):2308–2318.
   PubMed Web of Science ®Google Scholar
• Krilleke D, Ng YS, Shima DT. The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure–function study. Biochem Soc Trans. 2009;37(Pt 6):1201–1206.
   PubMedGoogle Scholar
• Choi DH, Lee D, Jo BS, et al. A synthetic cell-penetrating heparin-binding peptide derived from BMP4 with anti-inflammatory and chondrogenic functions for the treatment of arthritis. Int J Mol Sci. 2020;21(12):4251.
   Web of Science ®Google Scholar
• Cao XW, Yang XZ, Du X, et al. Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide. J Drug Target. 2018;26(9):777–792.
   PubMed Web of Science ®Google Scholar
• Bai XD, Cao XW, Chen YH, et al. Constructing a better binding peptide for drug delivery targeting the interleukin-4 receptor. J Drug Target. 2020;28(9):970–981.
   PubMed Web of Science ®Google Scholar
• Xu YY, Cao XW, Fu LY, et al. Screening and characterization of a novel high-efficiency tumor-homing cell-penetrating peptide from the buffalo cathelicidin family. J Pept Sci. 2019;25(9):e3201.
   PubMed Web of Science ®Google Scholar
• Guo Z, Peng H, Kang J, et al. Cell-penetrating peptides: possible transduction mechanisms and therapeutic applications. Biomed Rep. 2016;4(5):528–534.
   PubMed Web of Science ®Google Scholar
• Muramatsu T. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(4):410–425.
   PubMed Web of Science ®Google Scholar
• Yang J, Luo Y, Shibu MA, et al. Cell-penetrating peptides: efficient vectors for vaccine delivery. Curr Drug Deliv. 2019;16(5):430–443.
   PubMed Web of Science ®Google Scholar
• Antonella B, Anna T, Maria T, et al. Cell penetrating peptides as molecular carriers for anti-cancer agents. Molecules. 2018;23(2):295.
   Web of Science ®Google Scholar
• Ryu J, Kim H, Park HH, et al. Protein-stabilizing and cell-penetrating properties of α-helix domain of 30Kc19 protein. Biotechnol J. 2016;11(11):1443–1451.
   PubMed Web of Science ®Google Scholar
• Zhang F, Yang D, Jiang S, et al. Current delivery strategies to improve the target of cell penetrating peptides used for tumor-related therapeutics. Curr Pharm Des. 2018;24(5):541–548.
   PubMed Web of Science ®Google Scholar
• Quan X, Sun D, Zhou J. Molecular mechanism of HIV-1 TAT peptide and its conjugated gold nanoparticles translocating across lipid membranes. Phys Chem Chem Phys. 2019;21(20):10300–10310.
   PubMed Web of Science ®Google Scholar
• Kersemans V, Cornelissen B. Targeting the tumour: cell penetrating peptides for molecular imaging and radiotherapy. Pharmaceuticals. 2010;3(3):600–620.
   Google Scholar
• Lundberg P, EL-Andaloussi S, Sutlu T, et al. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J. 2007;21(11):2664–2671.
   PubMed Web of Science ®Google Scholar
• Kling J. Fresh from the biotech pipeline-2013. Nat Biotechnol. 2014;32(2):121–124.
   PubMed Web of Science ®Google Scholar
• Habault J, Poyet JL. Recent advances in cell penetrating peptide-based anticancer therapies. Molecules. 2019;24(5):927.
   PubMed Web of Science ®Google Scholar
• Islam MM, Odahara M, Yoshizumi T, et al. Cell-penetrating peptide-mediated transformation of large plasmid DNA into Escherichia coli. ACS Synth Biol. 2019;8(5):1215–1218.
   PubMed Web of Science ®Google Scholar
• Guidotti G, Brambilla L, Rossi D. Cell-Penetrating peptides: from basic research to clinics. Trends Pharmacol Sci. 2017;38(4):406–424.
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Jessop TC, Lewis RS, et al. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc. 2004;126(31):9506–9507.
   PubMed Web of Science ®Google Scholar
• Smith BA, Daniels DS, Coplin AE, et al. Minimally cationic cell-permeable miniature proteins via alpha-helical arginine display. J Am Chem Soc. 2008;130(10):2948–2949.
   PubMed Web of Science ®Google Scholar
• Ohgita T, Takechi-Haraya Y, Nadai R, et al. A novel amphipathic cell-penetrating peptide based on the N-terminal glycosaminoglycan binding region of human apolipoprotein E. Biochim Biophys Acta Biomembr. 2019;1861(3):541–549.
   PubMed Web of Science ®Google Scholar
• Fromm JR, Hileman RE, Caldwell EE, et al. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys. 1995;323(2):279–287.
   PubMed Web of Science ®Google Scholar
• Shin DH, Jo JY, Kim SH, et al. Midkine is a potential therapeutic target of tumorigenesis, angiogenesis, and metastasis in non-small cell lung cancer. Cancers. 2020;12(9):2402.
   Web of Science ®Google Scholar
• Malov SI, Malov IV, Kuvshinov AG, et al. Search for effective serum tumor markers for early diagnosis of hepatocellular carcinoma associated with hepatitis C. Sovrem Tekhnologii Med. 2021;13(1):27–33.
   PubMed Web of Science ®Google Scholar
• Libbrecht L, Severi T, Cassiman D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol. 2006;30(11):1405–1411.
   PubMed Web of Science ®Google Scholar
• O'Connell MP, Weeraratna AT. A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis. Pigment Cell Melanoma Res. 2011;24(6):1133–1147.
   PubMed Web of Science ®Google Scholar
• Kitaya K, Tada Y, Hayashi T, et al. Diverse functions of uterine proteoglycans in human reproduction (review). Mol Med Rep. 2012;5(6):1375–1381.
   PubMed Web of Science ®Google Scholar
• Nagarajan A, Malvi P, Wajapeyee N. Heparan sulfate and heparan sulfate proteoglycans in cancer initiation and progression. Front Endocrinol. 2018;9:483.
   PubMed Web of Science ®Google Scholar